Anzeige
Mehr »
Login
Dienstag, 16.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Im Fokus der Anleger: InnoCan Pharma vor entscheidendem Meilenstein!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PTXJ | ISIN: CA74319B5027 | Ticker-Symbol:
NASDAQ
12.04.24
20:32 Uhr
7,970 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PROFOUND MEDICAL CORP Chart 1 Jahr
5-Tage-Chart
PROFOUND MEDICAL CORP 5-Tage-Chart

Aktuelle News zur PROFOUND MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.04.Profound Medical Corp. - 6-K, Report of foreign issuer1
09.04.Profound Medical Corp.: Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference1
08.03.Profound Medical Corp. (PROF) Q4 2023 Earnings Call Transcript1
08.03.Earnings call: Profound Medical reports robust Q4 growth, eyes expansion2
08.03.Profound Medical Corp reports results for the quarter ended in December - Earnings Summary1
07.03.Profound Medical: Q4 Earnings Insights2
07.03.Profound Medical Corp (2): Profound Medical loses $33.37-million (U.S.) in 20231
07.03.Profound Medical Corp.: Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results264TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable...
► Artikel lesen
07.03.Profound Medical Corp. - 6-K, Report of foreign issuer1
04.03.Profound Medical Corp.: Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference1
01.03.Profound Medical (PROF), Siemens Unite to Treat Prostate Cancer7
27.02.Profound Medical, Siemens Healthineers collab on ultrasound ablation18
27.02.Profound Medical Corp (2): Profound, Siemens to collaborate to add MR to TULSA-Pro4
27.02.Profound Medical Corp. - 6-K, Report of foreign issuer1
27.02.Profound Medical Corp.: Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure296TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable...
► Artikel lesen
15.02.Profound Medical Corp. - 6-K, Report of foreign issuer1
15.02.Profound Medical Corp (2): Profound Medical to release 2023 results March 71
15.02.Profound Medical Corp.: Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 - Conference Call to Follow1
16.01.Profound Medical Corp. - 6-K, Report of foreign issuer1
16.01.Profound Medical Corp (2): Profound Medical arranges $2.93M (U.S.) placement1
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1